Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Starbucks Corp (SBUX) Price & Performance

Novartis AGTrade
Starbucks CorpTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Starbucks Corp — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while Starbucks Corp trades at $106.7 (market cap $121.59B). The key difference: Novartis AG is far larger — about 2.4× Starbucks Corp's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.

NVSSBUX
Market Cap
$295.37B$121.59B
Sector
HealthConsumer Cyclical
52-Week High
$168.62$108.37
52-Week Low
$119.31$78.46
Enterprise Value
$336.69B$140.42B
Dividend Yield
3.07%2.33%
Volume
7,493,833

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Starbucks Corp

Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.

Read more on SBUX